• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          “bill-haney” Archives

          in
          Entry Author Date Location
          New Faces, Big Impact: Meet the Finalists For Xconomy’s Newcomer Award Ben Fidler 08/07/18 Boston
          The 2018 Xconomy Awards Finalists Are… Corie Lok 06/28/18 Boston
          Skyhawk Lands $100M from Funding & Celgene Pact for RNA-Targeted Drugs Corie Lok 06/26/18 Boston
          Bio Roundup: Spark v. ICER, A Solid Revelation, T Cell Deals & More Alex Lash 01/26/18 National
          Disney, Family Offices Back Second Bio Startup from Tech Entrepreneur Haney Corie Lok 01/23/18 Boston
          Last Chance to Save on Boston’s Life Science Disruptors Jamie Gulden 09/20/17 Boston
          Dragonfly, eGenesis, Spero & More: Xconomy’s Startup Award Finalists Corie Lok 08/14/17 Boston
          Dragonfly, Tyler Jacks Sign On for Boston’s Life Science Disruptors on Sept. 28 Jamie Gulden 08/09/17 Boston
          Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal Ben Fidler 06/12/17 Boston
          MIT’s Jacks Leans on Disney Family, Not VCs, to Hatch New Startup Ben Fidler 08/11/16 Boston
          Page 1 of 1

          Underwriters and Partners

          Xconomy Insight
          • How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

            Xconomy Insight · Special Report

            How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

            Insights, wisdom, and inspiration on what it takes

          • Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development

            Sponsored · Webinar

            Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development

            Phenotypic Screening & Profiling to Understand a Compound's Disease Impact

            Eurofins Discovery
          • Potency Assay Development for Cell and Gene Therapy Products

            Sponsored · Whitepaper

            Potency Assay Development for Cell and Gene Therapy Products

            Create well-controlled, biologically relevant test systems and validate them to support FDA approvals

            Absorption Systems

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.